First Header Logo Second Header Logo

Connection

Mark Chappell to Nitric Oxide Synthase Type III

This is a "connection" page, showing publications Mark Chappell has written about Nitric Oxide Synthase Type III.
Connection Strength

0.911
  1. Chappell MC. Hydrogen sulfide, then nitric oxide and vasoprotection. J Hypertens. 2018 03; 36(3):493-494.
    View in: PubMed
    Score: 0.637
  2. Yamaleyeva LM, Lindsey SH, Varagic J, Zhang LL, Gallagher PE, Chen AF, Chappell MC. Amelioration of renal injury and oxidative stress by the nNOS inhibitor L-VNIO in the salt-sensitive mRen2.Lewis congenic rat. J Cardiovasc Pharmacol. 2012 Jun; 59(6):529-38.
    View in: PubMed
    Score: 0.107
  3. Gwathmey TM, Westwood BM, Pirro NT, Tang L, Rose JC, Diz DI, Chappell MC. Nuclear angiotensin-(1-7) receptor is functionally coupled to the formation of nitric oxide. Am J Physiol Renal Physiol. 2010 Nov; 299(5):F983-90.
    View in: PubMed
    Score: 0.095
  4. Yamaleyeva LM, Gallagher PE, Vinsant S, Chappell MC. Discoordinate regulation of renal nitric oxide synthase isoforms in ovariectomized mRen2. Lewis rats. . 2007 Feb; 292(2):R819-26.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.